Dallah Healthcare (4004.SR) Earnings Analysis
Dallah Healthcare (4004.SR) next reports earnings on 2026-08-10, consensus EPS 1.27 SAR. Last quarter (2026-05-10) it missed with EPS 0.84 SAR vs 1.32 SAR est (-36.4%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E 22.88.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4004.SR next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | 1.27 SAR |
| Revenue estimate | 1.16B |
4004.SR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-10 | 0.84 SAR | 1.32 SAR | -36.4% | Miss |
| 2026-03-04 | 1.61 SAR | 1.28 SAR | +25.8% | Beat |
| 2025-11-03 | 1.4 SAR | 1.08 SAR | +29.6% | Beat |
| 2025-08-04 | 1.23 SAR | 1.09 SAR | +12.8% | Beat |
| 2025-05-12 | 1.59 SAR | 1.21 SAR | +31.4% | Beat |
| 2025-03-05 | 1.17 SAR | 1.26 SAR | -7.1% | Miss |
| 2024-11-10 | 1.29 SAR | 1.23 SAR | +4.9% | Beat |
| 2024-08-05 | 1.15 SAR | 0.84 SAR | +36.9% | Beat |
Beat rate: 6/8 (75%) over reported quarters with consensus data.
4004.SR valuation and analyst view
| Trailing P/E | 22.88 |
|---|---|
| Trailing EPS | 4.648 SAR |
| Price / book | 2.59 |
| Dividend yield | 2.37% |
| Market cap | 10.60B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Dallah Healthcare (4004.SR)'s next earnings date?
Dallah Healthcare is next scheduled to report on 2026-08-10, with a consensus EPS estimate of 1.27 SAR and revenue estimate of 1.16B.
Did 4004.SR beat earnings last quarter?
In its 2026-05-10 report, 4004.SR posted EPS of 0.84 SAR versus a 1.32 SAR estimate — a miss of 36.4%.
What is 4004.SR's earnings track record?
Over the last 8 reported quarters with consensus data, 4004.SR beat estimates 6 times (75%).
What is 4004.SR's current P/E ratio and EPS?
4004.SR trades at a trailing P/E of 22.88 on trailing EPS of 4.648042944175553 SAR.
What do analysts rate 4004.SR?
4004.SR has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.